XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Tables)
3 Months Ended
Mar. 31, 2023
Equity  
Schedule of consolidated VIEs

As of March 31, 2023, we have the following consolidated VIEs (in thousands):

Gross

Investment

Property

Consolidated

Non-Controlling

Year

Purpose

Type

State

Assets

Interests

2023

Owned real estate

(1)

ALF/MC

NC

$

121,321

$

3,831

2022

Owned real estate

(2)

SNF

FL

76,756

14,325

2018

Owned real estate

ILF

OR

14,650

2,907

2018

Owned real estate and development

ALF/MC

OR

18,452

1,184

2017

Owned real estate and development

ILF/ALF/MC

WI

22,007

2,305

2017

Owned real estate

ALF/MC

SC

11,680

1,240

Total

$

264,866

$

25,792

(1)During the first quarter of 2023, we entered into a JV that purchased 11 ALF and MC with a total of 523 units. For more information regarding this transaction see Financing Receivable above in Note 2.

(2)During 2022, we entered into a JV that purchased three skilled nursing centers with a total of 299 beds. For more information regarding this transaction see Financing Receivable above in Note 2.
Schedule of cash dividends declared and paid

Distributions. We declared and paid the following cash dividends (in thousands):

Three Months Ended March 31, 

2023

2022

Declared

Paid

Declared

Paid

Common Stock (1)

$

23,563

$

23,563

$

22,480

$

22,480

(1)Represents $0.19 per share per month for the three months ended March 31, 2023 and 2022.

Schedule of restricted stock activity

The following table summarizes our restricted stock activity for the three months ended March 31, 2023 and 2022:

Three Months Ended March 31,

2023

2022

Outstanding, January 1

229,236

197,422

Granted

127,960

122,865

Vested

(98,206)

(83,341)

Cancelled

(1,085)

Outstanding, March 31

257,905

236,946

Schedule of restricted stock granted

No. of 

Price per

Year

Shares/Units

Share

Reward Type

Vesting Period

2023

127,960

$

37.16

Restricted stock

ratably over 3 years

86,867

$

37.16

Performance-based stock units

TSR targets (1)

214,827

2022

122,865

$

33.94

Restricted stock

ratably over 3 years

86,332

$

33.94

Performance-based stock units

TSR targets (1)

209,197

(1)Vesting is based on achieving certain total shareholder return (“TSR”) targets in 4 years with acceleration opportunity in 3 years.

Schedule of restricted common stock and performance-based stock unit scheduled to vest and remaining compensation expense At March 31, 2023, the remaining compensation expense to be recognized related to the future service period of unvested outstanding restricted common stock and performance-based stock units are as follows (in thousands):

Remaining

Compensation

Vesting Date

Expense

April - December 2023

$

6,071

2024

5,766

2025

3,238

2026

356

Total

$

15,431